Sanofi to acquire Qunol Ruchika Sharma28 July 2023 1:30 PM ISTParis: Sanofi has announced it has entered into a definitive agreement to acquire ownership of Qunol, a U.S.-based brand in health & wellness....
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
Sanofi Dupixent gets nod in India for treatment of adults with moderate-to-severe atopic dermatitis Ruchika Sharma11 July 2023 1:12 PM ISTDupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.
Nirsevimab delivers 83 percent reduction in RSV infant hospitalizations in a real world clinical trial setting: Sanofi Ruchika Sharma14 May 2023 2:00 PM ISTRSV is the most common cause of LRTD, including bronchiolitis and pneumonia, in infants.
Sanofi India demerger gets a green light Ruchika Sharma10 May 2023 5:33 PM ISTUpon completion of the proposed demerger, Sanofi will continue to own 60.4 percent stake in both entities and Sanofi India Limited shareholders will...
Sanofi concludes acquisition of Provention Bio Ruchika Sharma28 April 2023 12:30 PM ISTParis: Sanofi has announced the completion of its acquisition of Provention Bio, Inc.. The acquisition adds TZIELD (teplizumab-mzwv), a fully owned,...
Elisabeth Moreno to join Sanofi's Diversity, Equity and Inclusion Board Ruchika Sharma18 April 2023 2:30 PM ISTParis: Sanofi has announced the appointment of Elisabeth Moreno, former French Minister for Gender Equality, Diversity and Equal opportunities, to its...
US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris Ruchika Sharma18 April 2023 11:33 AM ISTSanofi said in the lawsuit that it lost hundreds of millions of dollars in sales in the USD 1 billion-plus U.S. epinephrine auto-injector market due...
AstraZeneca, Sanofi, Sobi simplify contractual agreements for Nirsevimab Ruchika Sharma12 April 2023 3:44 PM ISTBeyfortus (nirsevimab), an investigational long-acting antibody designed to protect all infants against RSV infections from birth through their first...
Sanofi to turn India consumer healthcare business into listed entity via demerger: Report Ruchika Sharma31 March 2023 12:00 PM ISTNew Delhi: French drugmaker Sanofi has started a process to turn its India consumer healthcare business into a listed entity via a demerger, the...
Diabetes drug: Sanofi gets marketing authorization from CDSCO for Soliqua Ruchika Sharma28 March 2023 3:14 PM ISTSoliqua (10-40 and 30-60 prefilled pens) is a once-daily injectable combination drug containing insulin glargine 100 Units/ml, which is a long-acting...
Sanofi Dupixent gets European Commission nod for children aged 6 months to 5 years old with severe atopic dermatitis Ruchika Sharma22 March 2023 12:45 PM ISTDupixent is an injection administered under the skin at different injection sites.
